Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase

被引:87
作者
Kilpatrick, Lynette M.
Harris, Roger L.
Owen, Kate A.
Bass, Rosemary
Ghorayeb, Christine
Bar-Or, Amit
Ellis, Vincent [1 ]
机构
[1] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
关键词
D O I
10.1182/blood-2006-02-001073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
uPA (urokinase-type plasminogen activator) activates plasminogen with high efficiency when bound to its cellular receptor uPAR, but only after a prolonged lag phase during which generated plasmin activates pro-uPA. How the activity of this proteolytic system might be rapidly initiated is unknown. We have now found that 2 monocytic cell lines display distinct patterns of plasminogen activation. U937 cells, but not THIP-1 cells, displayed the expected lag phase, suggesting a constitutive initiation mechanism on the latter. This was shown to be due to the plasmin-independent activation of uPAR-bound pro-uPA by a cell surface-associated protease and to correlate with the expression of matriptase, a type II transmembrane serine protease that was highly expressed in THP-1 cells but undetectable in U937 cells. Kinetic analysis demonstrated that matriptase is a relatively poor activator of pro-uPA in solution, approximately 100-fold less efficient than plasmin (k(cat)/K-m 1.16 X 10(5) M(-1)s(-1) cf 1.21 X 10(7) M(-1)s(-1)). However, down-regulation of matriptase expression in THP-1 cells by siRNA reduced the activation of cell-associated pro-uPA and the subsequent rapid initiation of plasminogen activation by 76% to 93%. Matriptase was also found to be expressed by peripheral blood monocytes and may therefore be a specific mechanism for the rapid initiation and regulation of plasminogen activation by these cells.
引用
收藏
页码:2616 / 2623
页数:8
相关论文
共 41 条
[1]   Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[2]   The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation [J].
Behrendt, N ;
List, K ;
Andreasen, PA ;
Dano, K .
BIOCHEMICAL JOURNAL, 2003, 371 (02) :277-287
[3]   uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[4]   Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator [J].
Bugge, TH ;
Flick, MJ ;
Danton, MJS ;
Daugherty, CC ;
Romer, J ;
Dano, K ;
Carmeliet, P ;
Collen, D ;
Degen, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5899-5904
[5]   THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS NOT ESSENTIAL FOR MOUSE DEVELOPMENT OR FERTILITY [J].
BUGGE, TH ;
SUH, TT ;
FLICK, MJ ;
DAUGHERTY, CC ;
ROMER, J ;
SOLBERG, H ;
ELLIS, V ;
DANO, K ;
DEGEN, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16886-16894
[6]   N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease [J].
Cho, EG ;
Kim, MG ;
Kim, C ;
Kim, SR ;
Seong, IS ;
Chung, CH ;
Schwartz, RH ;
Park, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :44581-44589
[7]   Shedding of membrane epithin is blocked without LDLRA4 and its protease activation site [J].
Cho, EG ;
Schwartz, RH ;
Kim, MG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (01) :328-334
[8]  
COLLEN D, 1986, J BIOL CHEM, V261, P1259
[9]   TARGETING OF THE SF HGF RECEPTOR TO THE BASOLATERAL DOMAIN OF POLARIZED EPITHELIAL-CELLS [J].
CREPALDI, T ;
POLLACK, AL ;
PRAT, M ;
ZBOREK, A ;
MOSTOV, K ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1994, 125 (02) :313-320
[10]  
ELLIS V, 1991, J BIOL CHEM, V266, P12752